Dr Rekha G Shah, MD in Columbia, MD - Anesthesiology

Dr Rekha G Shah, MD is a Anesthesiology physician based in Columbia, Maryland. Dr Rekha G Shah is licensed to practice in Maryland (license number D23645) and her current practice location is 11085 Little Patuxent Pkwy, Suite 004, Columbia, Maryland. She can be reached at her office (for appointments etc.) via phone at (410) 730-0099.

NPI number for Dr Rekha G Shah is 1457328353 and her current mailing address is 11821 Chapel Estates Dr, Clarksville, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1457328353.

Contact Information

	Dr Rekha G Shah, MD
	11085 Little Patuxent Pkwy, Suite 004, Columbia, MD 21044-2983
	(410) 730-0099
	Not Available

Physician's Profile

Full Name	Dr Rekha G Shah
Gender	Female
Speciality	Anesthesiology
Location	11085 Little Patuxent Pkwy, Columbia, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1457328353
Provider Enumeration Date: 03/01/2006
Last Update Date: 04/30/2015

Medical Identifiers

Medical identifiers for Dr Rekha G Shah such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1457328353	NPI	-	NPPES
329121900	Medicaid	MD

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207L00000X	Anesthesiology	D23645 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Rekha G Shah is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Rekha G Shah, MD 11821 Chapel Estates Dr, Clarksville, MD 21029-1164 Ph: () -	Dr Rekha G Shah, MD 11085 Little Patuxent Pkwy, Suite 004, Columbia, MD 21044-2983 Ph: (410) 730-0099

News Archive

Perseid Therapeutics to co-develop and commercialize next-generation CTLA4-Ig therapeutics

Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its majority-owned subsidiary, Perseid Therapeutics LLC, achieved a preclinical milestone under its collaboration with Astellas Pharma Inc. to co-develop and commercialize next-generation CTLA4-Ig therapeutics.

Early ritalin may cause long-term effects on the brain

A new study conducted in rats by the National Institutes of Health (NIH) and McLean Hospital/Harvard Medical School suggests that the misdiagnosis of attention-deficit hyperactivity disorder (ADHD) combined with prescription drug use in children may lead to a higher risk of developing depressive symptoms in adulthood.

New project aims to investigate food availability, security among indigenous populations in Australia

An international research team has received a $1.4 million grant from the Australian National Health and Medical Research Council to investigate food availability and food security among indigenous mothers and children in remote Australian communities.

Proton pump inhibitors linked to increased death risk

Proton pump inhibitors (PPIs) are one of the commonest agents prescribed for heart burn or acid reflux. These agents are available for purchase over-the-counter making them one of the most commonly used drugs that make around $10 billion in annual sales. PPIs work by reducing the production of the gastric acids in the stomach. There are several known risks associated with PPI use including complete stoppage of gastric acid production, risk of pneumonia, kidney disorders, bone fractures such as hip fractures etc.

Humira's early-line growth threatens Enbrel's future uptake in psoriatic arthritis

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that while Amgen/Pfizer's Enbrel was the most widely used tumor necrosis factor (TNF)-alpha inhibitor for recently treated psoriatic arthritis patients in the fourth quarter of 2010, Abbott's Humira has superseded Enbrel as an early-line TNF-alpha inhibitor for newly diagnosed psoriatic arthritis patients. Humira's early-line growth threatens Enbrel's future uptake in psoriatic arthritis.

Anesthesiology Doctors in Columbia, MD

Dr. James Strachan Houston, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10980 Grantchester Way, Columbia, MD 21044 Phone: 301-575-7338
Dr. Colleen Ceremuga, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10400 Little Patuxent Pkwy, Columbia, MD 21044 Phone: 888-339-8727
Danielle R Doyle, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7890
Dr. Bernard Marquis, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 11085 Little Patuxent Pkwy, Suite 004, Columbia, MD 21044 Phone: 410-730-0099
Dr. Annette G Folgueras, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8900 Columbia 100 Pkwy Ste E, Columbia, MD 21045 Phone: 443-221-4444 Fax: 410-730-7725
Gauri J Turner, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 11085 Little Patuxent Pkwy Bldg 4, Columbia, MD 21044 Phone: 410-730-0099 Fax: 410-964-1345
Mason Lane Dunham, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 11085 Litte Patuxent Parkway, Medical Arts Bldg, 004, Columbia, MD 21044 Phone: 410-730-0099 Fax: 410-964-1345

Dr Rekha G Shah, MD - Anesthesiology in Columbia, MD